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Prevalence of neurotic symptoms: a changing pattern
Jerzy W. Aleksandrowicz
Department of Psychotherapy, Collegium Medicum, Jagiellonian University Cracow
This study concerns changes in the prevalence of neurotic symptoms as re­
flected in symptom check-lists reported by 3586 neurotic patients treated in a 
specialised day-hospital from 1979 to 1999. The results show a transforma­
tion of the clinical picture over a period of 21 years. 
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Modem descriptions of neurotic disorders vary significantly from those presented 
in earlier papers [e. g. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12]. This may be due to a change 
in the manifestation of the illness, perhaps due to the growing knowledge of psycho­
pathology amongst the general public. Changes in the form of symptoms over years 
and their variability in different social milieus are usually explained by differences in 
socio-cultural influences as well as living conditions (e. g. type of stressing factors) 
which generate the psychopathologic phenomena. 
The course and direction of changes in the syndromes of neurotic disorders still 
remains unclear. Although the disappearance of some forms, e. g. “Grand Hysterie”, 
i. e. generalised hysterical seizures [13], seems to be evident, little is known whether it 
is the frequency of the particular symptom that changes or the whole syndromes or 
“disorders”. Similarly, there is no convincing evidence that the ever so less frequent 
diagnosis of psychastenia and a more common diagnosis of dysthymia or anxiety 
disorders is a result of objective changes of the symptomatology in the past century. It 
could be merely a consequence of the changing cognitive schema imposed by con­
temporary classification systems [14, 15, 16]. 
Moreover, even some convictions concerning neurotic symptomatology and epi­
demiology seem to be based on myths rather than on scientifically based knowledge. 
Such is, for instance, the case of the differences in the type and prevalence of neurotic 
symptoms in women and men [17], the growing numbers of neurotic disorders along 
with the development of the civilisation (especially the consequences of the socio­
economic and cultural conditions in technological societies), and so on. 
Having this in mind we conducted a study with the aim to answer the following 
questions: Does the prevalence of any specific neurotic symptom in a population of 
treated neurotic patients vary over time and if so what is the direction and the charac­
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ter of that change over a period of 21 years? Such a time span seems adequate for a 
change in the clinical picture to emerge. 
Material and method
The study used symptom check-lists “O” filled out by 3586 persons (2256 women 
and 1130 men) aged 19 to 68 years, mean age 36, 1 years). They were treated during 
the years 1979-1999 as Day-Hospital patients at the Centre for the Treatment of Neu­
rotic Disorders, Department of Psychotherapy, Jagiellonian University in Cracow. 
The “O” check-list provides indirect data about the appearance (during the last 7 
days preceding the examination) and the intensity of symptoms of some neurotic dis­
orders. The 138 items are arranged into 14 scales; SCL-“O” shows also some symp­
toms of personality dysfunction and of behavioural syndromes, which often accom­
pany the neurotic disorders. The scoring of GSI consists of simple addition of the 
following replies: “a” (ailment is insignificantly troublesome), “b” (medium trouble­
some) and “c” (significantly troublesome). This questionnaire correlates highly with 
SCL-90 and is even more reliable for the diagnosis of neurotic disorders. The detailed 
psychometric properties of the questionnaire were published previously [18]. 
The questionnaires were filled out by the patients during initial diagnostic exami­
nations, before the beginning of the therapy. Questionnaires with more than three 
missing answers were not included in the study. Those with improper data collection 
were also excluded; therefore the number of the analysed questionnaires was lower 
by 10, 2% than the number of persons treated in this time. 
Separation of the disorders into precise ICD-10 categories proved to be almost 
impossible due to changes in the diagnostic concepts which took place during the 
period under study. We can only roughly assume, that circa 25% of the population 
entered treatment because of various anxiety disorders (phobias, generalised anxiety 
disorder and others), approximately 20% because of somatoform disorders, circa 15% 
were suffering from dysthymia, circa 15% from dissociative disorders, and circa 5% 
had obsessive-compulsive disorder. Around 12% made up the category of “other neu­
rotic disorders”, especially neurasthenia, another 8% had diagnosis of behavioural 
syndromes (primarily eating disorders) and personality disorders not associated with 
manifested neurotic symptoms. The number of patients within any single diagnostic 
category treated in one year was very small. For this reason those data were not were 
not taken into account in the analysis. 
The patients were divided into groups according to the year of admission into 
treatment. Table 1 shows the number of patients treated in a single year, variations in 
the mean severity of the syndrome (GSI) and variations in the mean number of symp­
toms present during the following years. 
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Number of patients and the mean intensity of neurotic disorders (GSI of SCL-O)
Table 1
Year No. ofSCL"0"
Women Men Differences 
men vs womenNo. ofSCL mean GSI
Mean no. of 
symptoms
No. ofSCL 
mean GSI
Mean no. of 
symptoms
1979 124 80 438' 80. 8
44
321 64, 1 . 001
1980 109 67397 73. 4
42
337 67. 4 . 0. 5
1981 145 90409 77. 7
55
330 66. 3 . 01
1982 172 91440* 78. 0
81
371 73. 3 . 01
1983 120 60399 76.2
60
388’ 75.9 n.s.
1984 147 69425 77.4
78
357 70.2 .01
1985 169 79423 78.5
90
371 71.2 .05
1986 142 81425 79.8
61
359 71.9 .01
1987 134 75394 74.6
59
349 68.0 n.s.
1988 159 90408 75.8
69
346 68.1 .05
1989 153 103396 75.0
50
348 68.1 .05
1990 190 127419 78.5
63 
396’ 77.4 n.s.
1991 196 124409 77.8
72 
391 ' 75.2 n.s.
1992 182 112 428’ 79.8
70 
283 ** 57.6* .001
1993 180 124395 74.0
56
339 67.3 .05
1994 189 123403 76.3
66
372 73.5 n.s.
1995 202 135 379' 71.8
67
339 68.0 n.s.
1996 189 129381 71.7
60 
319' 65.5 .01
1997 200 146 376' 72.0
54
340 69.0 n.s.
1998 241 173 380’ 72.4
68
360 73.1 n.s.
1999 243 178390 74.6
65
356 68.8 n.s.
Long-term mean 402 75.7 353 69.7
S.D. 152 2.9 250 4.4
1 p<0.05;' p<0.01; ** p<0,001. The two highest GSI values and two highest mean numbers of symptoms are 
marked in bold, the two lowest are underlined.
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The number of people treated in each one year increased from 109 (in 1980) to 
241 (in 1998) due to the expansion of the institution and does not necessarily imply an 
increase in the number of persons requesting treatment. However, the differences of 
mean values of GSI, like the information concerning the mean number of symptoms 
in the different years, does not only describe the patient sample, but it indicates the 
mean severity of disorders of the patients at the time they decided to begin the treat­
ment. It also shows the relation between the number of symptoms and their intensity.
Out of the 138 variables in the symptom check-list “O”, 12 were omitted in the 
analysis - some are repetitions used for control of reliability and some are items in­
cluded in the SCL for clinical purposes but not connected directly with neurotic dis­
orders (e.g. allergic symptoms).
The prevalence of each symptom, i.e. the proportion of answers other than 0 on 
any of the 126 items in women’s questionnaires and 125 in men’s questionnaires’ was 
determined in each year. This was recorded regardless of the severity of the symptom. 
The number of replies, reporting the presence or on the absence of a symptom, was 
taken as 100%, even though it was slightly smaller than the number of questionnaires, 
for reason of an occasional absence of an answer.
The statistical significance of deviations of mean GSI values in any one single 
year from the long-term mean, was determined with a parametric test of statistical 
significance for the expected value (mean). The significance of differences between 
GSI of women and of men treated in the same year was determined with a t-student 
test (table 1).
The statistical significance of deviations from the mean value of the prevalence of 
a symptom was assessed by the test for two structure coefficients, measured in inde­
pendent trials. In case of extremely high or extremely small numbers of patients with 
such a symptom, the modification of Ferguson and Takane (1997) was used.1 2
1 One variable concerns menstrual disorders
2 Statistical analyses done by Adam Dębowski and Jan Przetacznik
Absence of a deviation from the mean on a level of at least p<0,05 level was 
considered as evidence of constant prevalence of a given symptom. Two or more 
statistically significant deviations from the long-term mean value were considered as 
a high probability of change of prevalence.
Results
The prevalence of 14 ( 11.1 %) symptoms in the female population and of 21 ( 16.8%) 
in the male population did not differ from the long-term mean. (See Table No 2).
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No statistically significant changes of symptoms’ prevalence
A. Women
Table 2
Variable
no.
Prevalence of symptom in a year (%) Long-term
 
m
ean1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
52 40 43 40 43 43 44 45 40 46 38 37 39 45 45 31 37 34 39 38 36 38 39.7
78 31 15 28 32 34 28 25 28 23 32 27 24 23 24 20 31 20 20 26 29 32 26.7
8 26 22 25 34 23 33 26 32 25 23 23 25 25 35 23 27 23 26 26 26 28 26.8
39 72 71 73 63 68 66 64 67 61 67 64 68 74 75 65 69 68 63 61 63 69 67.5
79 68 74 73 67 60 62 67 70 61 64 65 68 71 63 68 63 60 63 63 64 61 65.6
47 40 37 55 46 43 47 53 35 50 41 44 49 44 43 41 38 44 44 42 39 46 43.1
67 56 50 63 57 45 50 58 64 58 54 55 59 54 47 50 50 47 56 52 50 50 53.5
2 97 95 96 95 96 21 97 92 94 95 96 96 98 98 96 98 97 98 95 96 95 96.4
36 77 89 87 86 88 82 81 88 Z5 82 77 78 85 83 78 82 82 81 81 83 78 82.2
30 71 76 65 82 68 69 73 74 69 75 76 71 80 78 68 74 77 67 74 72 73 73.5
125 68 68 52 60 60 55 53 62 62 53 57 59 60 62 56 55 57 58 58 64 58 59.3
116 64 59 63 60 66 62 64 60 66 71 67 67 63 66 62 68 57 58 70 61 62 64.0
94 27 22 28 30 34 24 27 27 26 34 28 28 26 33 30 23 27 23 23 25 25 27.2
132 50 42 38 49 46 46 50 50 45 48 46 53 52 52 54 50 45 44 52 48 46 48.0
B. Men
Variable
no.
Prevalence of symptom in a year (%) Long-term
 
m
ean1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
18 84 73 83 88 78 82 85 80 81 85 87 79 77 80 78 83 76 76 90 83 80 81.9
58 40 42 40 45 41 37 43 31 40 47 40 49 43 31 28 43 35 38 40 45 47 40.9
32 23 50 23 43 46 50 43 57 45 51 41 55 56 35 42 54 41 43 38 50 46 46.4
61 15 19 16 14 28 23 30 19 23 28 21 25 30 12 16 19 22 25 22 25 16 22.1
121 38 50 40 50 64 43 54 52 55 52 56 63 55 47 50 60 52 44 53 60 55 52.7
8 18 16 23 24 26 17 21 24 22 27 16 26 26 14 23 25 25 26 29 30 27 23.7
128 50 40 41 23 44 37 47 39 35 36 41 49 48 34 30 50 40 33 49 35 44 40.8
7 50 50 61 67 61 60 55 57 52 54 62 43 52 52 66 66 56 60 71 57 62 58.5
22 59 54 52 56 60 52 64 55 55 65 72 66 69 58 69 65 65 66 57 69 67 62.2
36 84 71 70 80 73 73 81 85 72 69 75 74 84 53 75 75 82 81 75 82 78 77.1
56 72 83 74 77 80 78 81 75 74 78 74 85 77 71 75 80 77 71 75 77 70 76.9
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26 75 69 SI 69 69 71 76 73 72 76 63 77 72 67 62 75 67 71 64 75 72 71,1
66 88 85 81 90 93 92 86 93 91 81 87 88 91 85 87 81 82 80 88 85 86 87,2
75 68 64 61 72 78 67 68 68 66 65 80 65 76 sa 66 66 73 66 72 67 70 68,8
125 54 45 41 54 56 48 53 45 44 46 47 55 59 44 51 57 55 50 53 55 58 51,7
110 52 61 47 53 56 43 55 50 42 53 50 57 55 41 48 57 61 51 55 54 49 52,2
94 22 38 27 34 34 30 25 31 33 26 23 28 30 24 IS 33 25 30 27 29 24 28,6
103 47 45 61 53 63 53 53 63 49 52 43 60 51 42 57 56 47 51 48 52 52 52,9
113 50 57 60 62 55 58 60 62 54 56 51 60 55 51 59 50 4S 53 52 49 55,3
117 40 45 45 46 58 44 55 55 50 43 41 52 45 44 48 53 40 44 35 41 36 46,5
132 36 28 32 37 53 47 45 39 44 42 43 47 43 38 35 43 47 44 50 51 44 43,1
The highest values are marked in bold, the lowest are underlined. Numbers of variables with constant preva­
lence in both gender populations are marked in bold.
Obsessive and compulsive symptoms: obsessive thoughts, compulsions and ideation - variable number 18, 
those of blasphemous and obscene content - number 58, need to unnecessarily repeat actions - number 32, 
need to wash one’s hands, touch objects, etc. - number 52, need to count lampposts, cars, etc. - number 78, 
anxiety symptoms: Feeling afraid in open spaces or on the street - number 61, unjustified anxiety about closest 
relatives - number 121, derealisation: feeling of unreality of certain objects - variable number 8, feeling of low 
intensity of experiences - number 128, sleep disorders: difficulty in falling asleep - number 39, frequent awak­
ening at night - number 79, sexual dysfunctions: dissatisfaction with sexual life - number 7, lack of sexual 
interest - number 47, considerably lowered or absent sexual drive - number 67; depressive: lowered mood - 
number 2, feeling guilty, blaming oneself - number 22; others: absent-mindedness - number 36, “nervous­
ness”, motor tension - number 56, memory impairment - number 26, difficulty in concentrating - number 66. 
low self esteem - number 75, feeling of alienation - number 30 and 125, feeling that the outer world is unfriend­
ly-number 110, constant anger, irritation - number 116; somatic dysfunctions: excessive salivation - number 
94, trouble getting your breath - number 103, tremor of eyelids, face, head, etc. - number 113 and undefined 
“migrating” aches - variable number 117, polyuria - number 132 (numbers applying to female population only 
were presented in italics).
A considerable majority of the variables - 112 among women (88,9%) and 104 
(83,2%) among men - showed at least one statistically significant deviation at the 
level of p<0.05 from the long-term mean of symptom prevalence. (In 53 variables out 
of the 112 in the female group and in 45 of the 104 in the male group, the level of 
significance was at p<0,01 or p<0,001.)
In the female population, significant deviations in only one of the years were ob­
served in 35 variables (27,7% - numbers 7, 13, 15, 18, 25, 27, 28, 33*, 35, 37* 38*, 
41,42, 46*, 48*, 49, 53, 55*, 61, 65, 66, 70, 72*. 73*, 74*, 75, 80*, 90*, 107, 108, 
110, 115, 118*, 131,137), in the male population in 32 variables (25,6%-numbers 1, 
3, 12, 17, 33*, 34, 37*, 38*, 43, 46*, 48*, 50, 51, 52, 55*, 60, 62, 63, 67, 72*, 73*, 
74*, 80*, 83, 90*, 93, 95, 98, 106, 118*, 126, 135)?
’ See tables in the annex. Variables with an asterix are those where significant differences were 
present in both male and female populations.
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At least two statistically significant deviations (on the level of at least p<0,05) 
from the long-term mean value was observed in 77 variables in the female population 
(61,1%) and in 72 (57,6%) among men. The largest number of significant deviations
- seven - were observed in the variable number 40 (pain in heart and chest) and - six
- in the variables number 29, 113, 117 and 123 (also somatic symptoms), all in the 
female population. Five significant deviations were observed in the female popula­
tion, namely variables number 14, 54, 59, 71, 83 and 106, and four in the male popu­
lation namely variables number 9, 68, 116 and 124.4
4 29 - headaches, 113-Trembling (of eyelids etc), 117 - "migrating" aches, 123 - lack of balance, 
14 - vertigo, 54 - loss of appetite, 59 - hunger strikes, 71 - anxiety in closed spaces, 83 - fainting 
and 106 - difficulty in thinking; 9 - vomiting, 68 - depersonalisation, 116 - constant feeling of 
anger and 124 - anxiety of loosing control.
In some variables, the statistically significant deviations from the long-term mean 
occurred only in one direction (increase or decrease of prevalence). In the female 
population, these were the following variables: number 4, 44 and 58 (see table 3), 
number 10, 34, 56, 77 and 93 (see table 4), 21, 84, 99, 124 and 138 (table 5), 81, 82. 
105 (table 6) and 127 (table 7); in the male population: 31, 81, 115 (table 3), 29 and 
40 (table 4), 64 and 123 (table 5), 2, 6, 30 and 105 (table 6), 84 and 136 (see appen­
dix).
In 48 variables at last two significant deviations from long-term mean prevalence 
occurred in both genders. In 29 variables they occurred only in the female group 
(variables 1, 3, 12, 17, 22, 26, 32, 34, 43, 50, 51, 56, 58, 60, 62, 63, 83, 93, 95, 98, 
103, 106, 113, 117, 121, 126, 127, 128, 135); in 24 variables these deviations were 
observed only in the male population (variables no 2, 13, 15, 25, 27, 28, 30, 35, 39, 
41, 42, 47, 49, 53, 65, 70, 78, 79, 107, 108, 115, 116, 131, 137. (In total - 77 in the 
female and 72 in the male population).
In both gender populations the prevalence of five symptoms was gradually rising 
(especially in the years 1993 - 1999): persistent anxiety (variable number 4), panic 
attacks (number 44), depersonalisation (feeling of unreality, strangeness of one’s own 
body - number 68), flatulence (number 31), hunger attacks (number 59). Among the 
women, the increase in the prevalence of symptoms was also noticed in two variables: 
number 22 - feelings of guilt, number 58 - blasphemous or indecent thoughts and 
ideation (the prevalence of these symptoms among men was relatively constant, see 
table 2). In the male population the prevalence of two variables increased: number 81
- anxiety when being in a crowd (for women - see table 6) and number 115 - feeling 
of dependence (for women - see appendix). The graphs of these changes in preva­
lence are presented in table 3.
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In other variables an opposite tendency, i.e. a tendency of decrease in the preva­
lence of the symptoms within the passing years was observed in both gender popula­
tions. Those variables included tiredness (number 86), anxious expectations (stage 
fright - number 104), social phobia (number 10), pain in heart and chest (number 40), 
headaches (number 29), muscle pains (number 134), sensory conversions (temporary 
loss touch or pain sensation- number 23), loss of appetite (number 54 - table 4a).
Some symptoms, especially dysthymic and somatic ones, occurred less frequently 
with the years exclusively in the female population5 or exclusively in the male popu­
lation. They are represented in table 4b.
5 In the male population, besides variables 77 and 136 (see table 7b) there is only one significant 
deviation from the long-term mean value (see annex) or no deviation. Variables 25 and 119 in the 
female population - see annex.
Prevalence changes of some symptoms were fairly parallel both in women and 
men (for instance the variable number 59, table 3). Other examples are presented in 
the table 5A.
Most of the symptoms change their frequency in the female population in other 
periods than in the male population. This difference can be seen in the variables num­
ber 16 - feeling of tension, 9 - vomiting in situations of nervousness, 69 - diarrhoea, 
101 - specific phobias, animals, objects and places 129 -muscle tension, 76 - aggres­
sion outbursts on objects, 114 - increased sweating, 5 - tendency to cry frequently, 96 
- uncontrolled outbursts of anger, 124 - feeling afraid of loosing control, catastrophic 
anxiety, 138 - deja vu, 21 - anxiety in loneliness e.g. in an empty flat, 88 - feeling of 
living in a dream, 89 - muscle fibrillation, trembling, 123 - lack of balance, 99 - 
insomnia, 84 - feeling of undefined danger. Sometimes the directions of changes in 
males and females were even in the opposite direction. Examples of that are present­
ed in table 5B (also see variables number 40 and 59 in table 4).
Sometimes the prevalence change of different symptoms was almost parallel. Be­
side the course of symptoms’ changes presented in other tables (for instance in female 
population - fainting, number 51 and faintness, number 83, see table 4; in men’s 
population - hypochondriac symptoms, variables number 57 and 97, see table 5A 
etc), some groups of symptoms, whose prevalence changed in the same rhythm (other 
in female population, others among males - for example variables number 20, 45, 
105) are presented in the table 6 A and B.
Other symptoms, beside the ones presented in the tables 3, 4 and 6, whose prev­
alence differed from the long-term mean value only in female population or only in 
male population, are presented in table 7. It includes also other variables, which were 
not shown in other tables and which showed some essential deviations (119, 6, 77, 
82, 36).
The number of symptoms, whose prevalence differed significantly from the long­
term mean, was especially high during some years and very low in the other years. 
Table 8 shows the symptoms, whose prevalence changed only in one out of the annu­
al periods (in total - 112 variables in women’s population and 104 in the male popu­
lation).
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Number of statistically significant deviations of frequency of symptom prevalence
in the following annual periods
Table 8
Year
WOMEN MEN
prevalence 
increase
prevalence 
decline
prevalence 
increase
prevalence 
decline
1979 22 1 0 12
19S0 2 9 2 2
1981 13 7 0 11
1982 9 3 18 3
1983 6 5 12 0
1984 3 3 3 2
1985 3 0 2 1
1986 18 3 4 0
1987 0 7 1 3
1988 2 1 1 6
1989 4 2 5 2
1990 11 1 21 0
1991 5 0 12 0
1992 16 1 0 49
1993 4 7 1 2
1994 4 0 12 0
1995 1 13 2 5
1996 0 17 1 10
1997 0 23 1 3
1998 3 22 6 0
1999 9 13 5 2
The deviations from the long-term mean in each of these periods were related to 
symptoms of various kinds, however some specific patterns can be seen. For instance, 
in the female population: in 1981, the prevalence of somatic symptoms increased 
almost exclusively: (11 out of 13 - approximately 85%), in 1979 the somatic symp­
toms amounted for half (11) of the symptoms, and likewise in 1992 (8), while in 1986 
the prevalence of only 2 somatic dysfunctions increased (11%), less than that of anx­
iety symptoms (4). In 1997 the prevalence of many anxiety symptoms and phobias 
decreased, as well as that of hypochondriac ones (3), in 1998 - 14 (64%) of somatic 
symptoms. In the male population: in 1982 there was an increase in the prevalence of 
6 somatic symptoms (33% out of 18) and of three other variables related to sleep 
disorders, in 1990 the prevalence of many somatic symptoms rose (8 - 38% out of 21 
(18%)), as well as that of anxiety ones (4 symptoms) and of hypochondriac (4). Out of 
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49 symptoms, whose prevalence decreased in 1992, there were 9 anxiety symptoms. 
More precise analysis of these data goes beyond the scope of this publication.
Discussion
The data presented here provide considerable material for further research of many 
aspects of the specificity of neurotic disorders. For the sake of scope limitations, only 
the “hard data” are presented in this paper. It is worth noticing however, that almost 
all the symptoms occurred in at least 50% of patients, but not in every year. Data 
concerning the differences in prevalence of symptoms belonging to the same group 
(for example: derealisations, compulsions, hypochondriac symptoms) and the rhythm 
differences of these prevalence changes seem noteworthy; and so are data regarding 
similar prevalence as well as of similar mean number of symptoms in women and in 
men etc. The data regarding the differences of population of patients in treatment in 
the consecutive years seem also to be very important. For instance, the number of 
women and men entering treatment, the periodic differences (or absence of differenc­
es) in the intensity of disorders (mean values of the GSI) in women and in men [table 
1], especially its relation to the economic, political and socio-cultural situation, re­
quire additional studies.
The results of this study need to be treated very cautiously, for two reasons at least. 
Firstly, the division into sub-groups of persons treated within one calendar year is 
purely artificial. It is the optimal way to organise the data easily and to create ade­
quately numerous sub-groups, but probably makes it more difficult to disclose the 
nature of prevalence changes of the symptoms. Secondly, the results describe only 
symptom prevalence changes of symptoms in persons entering treatment of neurotic 
disorders and cannot provide direct information on the changes in neurotic disorders’ 
symptomatology. Last but not least, it is open for discussion whether self-reporting of 
the symptoms in the symptomatic questionnaire is a more or less reliable information 
regarding the existence of a symptom, than the psychiatric examination protocol [18]. 
As a matter of fact, the patients’ responses on the questionnaire items express only - 
like a complaint - the presence of distress connected with a symptom and not the 
symptom itself.
Despite of all these reservations, it seems probable that the results of this study 
confirm the existence of a transformation of neurotic syndromes. In the 21 years, the 
apparent prevalence of approximately 60% of the symptoms, to which the “O” check­
list variables refer, differed at least twice from the long-term mean value on a statisti­
cally significant level. In another circa 25% of variables, at least one such difference 
was noted. Like the multiple changes in the prevalence of some symptoms (especially 
heart pain, headaches, muscle trembling, unspecified pain ailments and balance dis­
orders, especially in the female population), it indicates the probability of a variation 
in the particular symptom appearance. Absence of statistically significant deviations 
from the long-term mean was found in only 11 % of the female population and in only 
17% of variables in the male population.
Those differences cannot be explained either by the nature of those symptoms, nor 
by the mean value of their prevalence. Taking into account the number and the distri­
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bution of changes in symptom prevalence in the consecutive one-year periods, those 
differences also cannot be attributed to possible proportion changes of persons being 
treated because of various neurotic disorders. Such a possibility requires however 
verification in additional studies.
In the women’s population, a slightly larger number of symptoms changed their 
prevalence than in the male population. It is coherent with a common impression that 
changeability of symptoms in women is larger than in men. Differences are however 
not very large despite a relatively large number of sub-groups treated in the yearly 
periods, and therefore those differences can be accidental and can be linked related to 
the lower number of men’s sub-groups. In the years when a considerable number of 
male patients were treated (1984 and 1985, table 8), the number of significant devia­
tions from the mean value was similar in both populations. In some periods even 
prevalence changes in a significantly larger number of symptoms were observed in 
the men’s population than in the women’s one.
It seems however, that in spite of the absence of larger differences in number and 
kind of symptoms there are some differences in symptom changing process’ specific­
ity in the female and male populations. The direction of changes in prevalence is 
seldom quite parallel in both populations. Generally, those changes appear in differ­
ent periods in the female than in the male population. At times the prevalence of one 
symptom in the women’s population increased even as it became rare among men (for 
instance pain in heart or chest and loss of appetite (the variables number 40 and 54) in 
1992, table 4). Moreover, in the periods, when the changes were especially numerous 
(table 8), the direction of prevalence changes was different in the women’s and men’s 
populations - only in 1990 simultaneous increase in the prevalence was observed and 
in 1996 a decreased prevalence of many symptoms in both populations was noted.
One tendency appeared in all the patients, namely that the prevalence of some, 
mainly anxiety symptoms rose with time - i.e. generalised, free-floating anxiety and 
panic attacks, also one of the depersonalisation’s symptoms as well as two somatic 
ailments - flatulence and hunger attacks. In the women’s population there is a tenden­
cy to experience feelings of guilt and obsessive thoughts of blasphemous content 
more often; in the male population - the observed tendency is to feel more often 
excessive dependency and agoraphobic fears.
The number of symptoms, whose prevalence increased with the passing years, 
was lower than of those, whose prevalence decreased. They were (in both popula­
tions): feeling of tiredness, of fearful expectations, one of the social phobia symptoms 
(feeling not well in a large social group), sensory conversions (loss of tactile and pain 
feeling), heart pains, headaches, as well as muscle pains and loss of appetite. Further­
more, in the female population the frequency of 18 other symptoms decreased. These 
were the following symptoms: avoidance of people, skin itching, memory gaps, feel­
ing of difficulty in thinking, vertigo, fainting, collapses, feeling of energy loss, diar­
rhoea, hypersensitivity to light, sound, touch; unspecified “relocating” pains, suicidal 
tendencies, blood flushes to the head, feeling pale, rush of ideas, movement tension, 
fear of falling sick, excessive saliva production. In the male population only preva­
lence of two symptoms decreased: excessive intensity of experiences and sleepiness 
episodes during the day.
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Difference between the number of symptoms, whose prevalence decreased with 
years; and the number of symptoms, which became more frequent, can be linked - to 
some extent at last - with the fact, that the treatment was initiated by persons with a 
lower than mean intensity of the disorders (women in years 1995 - 1999, men in 1992 
etc.). This hypothesis is contradicted, however by the constancy of the mean number 
of symptoms, as expressed in SCL. In the female population, these mean values did 
not differ significantly from the long-term mean in any of the periods and in the male 
population only one statistically significant difference was seen (in 1992, see table 1).
The research results indicate that this stability in the mean number of symptoms is 
connected with irregular, transitory prevalence increase or decrease of particular symp­
toms in various periods. As it seems, such results confirm the thesis that the complex 
of neurotic symptoms is a system - a structured set, in which individual elements 
(symptoms) change under the influence of circumstances, exterior in respect of such 
a system, but not changing the whole system’s core [19].
Sometimes, the prevalence of a particular symptom was higher in women and in 
other periods in men (for example specific phobias - variable number 101, see table 
5A). This puts doubt on the results of researches concerning prevalence of neurotic 
symptoms, which did not take into consideration the phenomenon of periodical changes 
of this prevalence, even they are performed on numerous populations (for instance, 
analysis of a significant part of the same material collected in the years 1978 - 1997 
[20]). For example, in this study anxiety (uneasiness) in the population of 1970 wom­
en and of 1226 men - appeared statistically significantly more often in women (94,9%) 
than in men (91,85%). However, in the sub-groups being in treatment in the years 
1991 and 1999 it appeared more frequently in men than in women (variable number 
64, table 5A).
In some periods, there were more frequency changes than in others (see table 8). 
Some prevalence changes of symptoms seem to be directly linked with the social 
situation - for example increase in the prevalence of feeling of tension in the female 
population in 1989 and in the male population in the years 1982 - 1983 or in 1991 
(variable number 16, table 5B). Deep socio-political, economic and cultural changes 
were taking place in Poland in those years. Probably deeper analysis of the relation 
between the changes in the prevalence of some symptoms (especially somatic symp­
toms and sexual dysfunctions) and such socio-cultural factors, will lead not only to an 
explanation of the phenomenon of changes in prevalence but also to an understanding 
of their symbolic functions.
Conclusions.
The research results indicate that the frequency of neurotic symptoms changed 
during the 21 years. Sometimes it changed even dramatically fast - the statistically 
significant deviations from the long-term mean value in the direction of frequency 
increase and decrease, occur even in the annual periods. This causes significant changes 
of the neurotic disorders’ symptomatology.
Frequency changes of the majority of symptoms described in SCL “O” were noted 
both in the female and in the male population. Frequency of some symptoms changed
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only in women or only in men. Those changes did not affect the general number of 
symptoms, similar (only slightly bigger) in women’s population.
Symptoms, of which the frequency is relatively constant, like the frequency of 
those symptoms, of which the frequency changes - are the symptoms of various neu­
rotic disorders.
Frequency of all symptoms in the whole population explored is considerably high­
er than the expected one due to the type of diagnosis. Higher or lower frequency of 
any symptom appearance is not linked with the incidence of a change of this frequen­
cy. This makes the basic concepts of neurotic disorders classification very doubtful.
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ANNEX
I. Only one significant deviation from the long-term mean value - women
Year^^
"Variable no
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
Long-term
 
m
ean
15 82' 71 64 79 64 69 78 69 73 71 72 67 77 75 67 73 74 71 72 68 75 72.5
49 73' 62 66 67 61 59 67 59 65 56 53 61 57 66 57 69 55 55 62 59 60 612
61 38' 29 28 31 25 24 36 32 36 33 22 30 34 24 23 25 24 24 28 28 28 28.7
75 87’ 70 72 82 73 75 83 75 n Tl 81 80 71 75 72 79 81 76 80 81 73 77.7
110 76" 56 66 58 63 57 59 66 51 60 53 55 61 55 52 57 57 50 55 54 53 57.4
7 44 40' 44 60 53 53 62 56 50 53 54 57 55 53 52 51 48 49 55 47 53 52.3
118 66 47’ 61 58 58 62 55 62 62 58 . 63 62 59 68 58 63 57 61 64 58 62 61.0
137 51 31’ 48 40 48 40 46 45 45 40 40 48 45 41 41 45 37 50 42 42 37 43.2
74 37 44 56' 50 48 42 36 48 51 52 45 51 50 42 39 39 42 45 50 42 41 45.4
55 77 65 58’ 65 64 68 72 64 62 67 70 70 68 73 63 70 71 73 70 69 71 69.2
115 64 62 52’ 71 61 68 65 58 59 64 59 64 67 67 58 64 70 66 68 65 65 64.5
80 58 47 48 61' 50 52 56 50 41 50 48 52 50 42 52 40 45 43 47 46 43 48.5
90 63 55 53 72’ 60 59 62 65 51 60 61 56 64 59 60 64 64 60 67 68 64 62.3
108 34 34 38 45’ 40 40 32 33 38 29 30 35 28 35 29 28 30 31 30 38 35 34.0
33 25 26 28 25 36’ 26 29 25 17 18 25 21 19 18 20 21 20 19 25 28 24 23.6
46 87 77 81 85 71 76 81 90' 72 77 75 85 84 82 78 78 77 79 77 74 80 79.7
65 60 55 60 67 68 63 60 75’ 57 58 66 60 66 67 58 58 65 57 67 60 66 62.9
42 93 91 81 87 80 89 89 ZS’ 80 82 88 88 91 91 87 90 88 86 89 87 83 87.1
48 27 40 37 42 38 36 36 38 25’ 33 34 30 29 42 30 39 40 34 38 35 42 36.2
72 78 82 80 84 76 76 78 83 68’ 76 81 79 81 83 77 80 73 77 74 76 74 78.2
28 43 50 51 52 46 44 45 51 42 35’ 49 48 45 47 38 43 44 44 46 46 44 45.8
25 86 91 94 94 91 91 89 93 86 91 96’ 92 90 93 87 88 87 87 89 89 86 90.1
35 89 82 86 89 86 86 93 82 86 89 95’ 85 94 94 89 91 88 91 89 89 86 89.1
18 75 80 80 86 80 85 84 85 74 84 77 88’ 87 87 •85 83 80 75 78 78 76 81.5
131 43 26 44 32 34 36 46 32 36 41 33 46’ 41 34 33 38 37 31 37 36 34 37.2
37 46 50 47 53 43 53 50 56 47 47 42 52 62* 54 48 55 50 47 43 43 48 49.7
70 48 37 41 50 36 37 51 38 45 43 44 45 37 28’ 41 39 35 41 41 45 45 41.8
66 93 94 92 90 91 86 84 95 82 92 89 89 93 87 83' 91 84 86 89 91 88 89.3
13 44 40 48 43 34 40 40 44 36 42 37 50 49 51 41 50 34' 43 38 42 45 43.3
73 28 26 30 29 21 24 26 28 22 27 29 26 27 24 22 28 23 12’ 21 20 30 25.5
41 47 46 42 41 33 52 50 44 47 50 45 44 42 40 46 44 37 36 33' 36 41 42.2
27 31 25 26 30 31 21 26 23 25 23 22 30 28 31 25 27 25 20 25 19’ 22 25.5
38 31 20 23 28 30 21 25 29 21 23 27 25 33 37 27 35 28 29 34 32 43" 30.2
53 38 31 34 36 36 30 39 33 36 26 31 36 33 36 33 39 33 29 31 29 42’ 34.2
107 28 22 26 31 30 28 26 30 30 24 28 25 26 29 30 30 28 24 21 23 34’ 27.8
'p<0.05; *p<0.01; "p<0.001. The statistically significant deviations above the mean value are marked in bold, the deviations below the 
mean are underlined.
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II. Only one significant deviation from the long-term mean value - men
\ Ś 
\ ® 
§“\ 
S' \ 
CT \
p ’
1979
1980
1981
1982
1983
i
1985
1986
1987
i
1989
i
1991
1992
1993
1995
1996
1997
1998
1999
Long-term
 
m
ean
37 34’ 42 56 50 55 41 50 55 52 45 48 61 55 41 57 57 53 48 61 44 43 50.3
52 27.’ 35 34 51 51 44 38 45 45 50 37 50 52 35 42 42 37 50 33 38 44 43.0
36 38 28 18.’ 28 26 28 32 34 28 26 36 31 37 22 37 40 35 30 33 42 40 32.2
62 34 33 20’ 38 38 33 35 27 42 27 40 33 37 27 28 31 34 40 37 32 44 34.2
67 43 35 52 48 63’ 50 51 52 52 40 54 55 52 47 57 62 49 50 50 44 46 50.5
74 29 33 18 27 40’ 29 27 26 30 27 30 31 27 17 21 33 19 25 24 25 26 27.0
83 15 33 27 27 36’ 26 20 32 25 23 20 31 23 17 17 18 19 23 16 20 23 23.7
34 45 47 56 61 63 52 66’ 59 55 62 51 63 54 45 53 50 46 51 48 57 58 55.4
12 59 64 56 74 68 62 60 80’ 71 69 60 74 68 60 60 63 71 61 68 66 69 66.3
95 56 64 49 56 63 47 58 49 66’ 61 56 57 52 45 44 45 44 48 46 58 49 53.3
55 61 54 52 67 63 52 56 68 54 51’ 56 73 66 57 69 66 67 58 70 66 69 62.1
72 77 69 60 65 73 66 75 75 64 65 54’ 69 76 61 64 57 70 63 70 65 64 67.2
17 59 54 65 61 69 64 58 73 61 56 72 82* 66 60 71 71 64 64 67 63 61 65.1
60 50 54 58 53 50 56 61 55 50 55 43 68’ 63 44 60 59 49 50 48 66 44 54.8
43 20 23 23 20 20 20 20 21 25 21 20 15 30* 14 12 21 19 20 15 16 15 19.9
3 45 45 45 59 66 55 53 57 52 55 60 61 65 42.’ 62 59 49 53 50 63 60 55.7
46 77 66 72 82 76 79 77 78 76 72 83 82 81 65’ 69 72 73 76 79 79 81 76.7
48 31 33 27 30 40 24 36 36 25 40 25 38 34 20’ 37 39 34 33 38 44 40 33.9
50 56 57 52 64 61 56 58 54 64 55 68 68 63 45* 55 68 67 51 72 64 61 60.3
51 04 19 18 08 11 15 20 16 13 17 14 12 18 04’ 10 12 16 18 09 08 12 13.5
90 50 52 52 65 64 61 56 57 55 50 66 58 59 31’ 46 57 56 51 57 64 56 56.5
98 45 50 52 56 55 50 47 39 45 52 37 52 48 35’ 41 51 47 40 35 57 49 47.5
106 68 71 74 82 75 79 80 81 76 73 69 82 81 61’ 73 75 77 66 81 79 81 76.6
118 54 66 50 54 61 50 57 52 52 55 50 60 55 40’ 48 56 56 46 53 61 55 54.2
126 81 88 70 82 71 79 78 81 74 79 74 79 84 67’ 71 78 74 80 87 79 72 77.9
63 27 35 41 32 31 32 30 31 22 26 21 31 38 30 11’ 36 35 28 20 33 33 30.6
73 25 21 27 24 26 28 21 27 23 26 18 26 26 15 25 37’ 29 2G 22 28 20 24.9
80 27 40 45 37 33 37 40 44 38 33 40 42 43 30 32 53’ 34 40 44 39 40 38.9
93 34 38 43 51 55 53 43 39 45 42 54 47 45 37 41 57’ 38 43 48 44 33 44.9
1 36 42 50 44 51 47 41 49 47 39 43 53 51 35 41 36 34 31’ 44 38 32 42.4
33 29 33 36 29 30 37 26 31 37 28 36 34 20 25 17 30 23 11’ 27 32 36 29.4
135 31 38 40 39 51 46 40 49 35 46 31 47 45 31 46 34 29 28 21’ 44 40 39.6
■p<0.05; *p<0.01; **p<0.001. The statistically significant deviations above the mean value are marked in bold, the deviations below lhe 
mean are underlined.
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TABLE I
Symptoms: 15 - feeling of a lack of independence, 49 - dry mouth, 61 - Feeling afraid in open 
spaces or on the street, 75 - low self esteem, 110 - unfriendly outer world, 7 - dissatisfaction with the 
sexual life, 118 - feeling of protest/rebellion, 137 - potency reduction, 74 - constipation, 55 - feeling 
of helplessness, 115 - feeling of dependence, 80 - getting red on the face, neck, 90 - feeling of 
being under other peoples influence, 108 - déjà vu, 33 - stuttering, 46 -feeling of lower brightness of 
thinking, 65 - lack of control of emotions' expression, 42 - lost belief in own strengths, 48 - feeling 
of the world as unreal, 72 - psycho-motor function slowing down, 28 - derealisation (foggy world), 
25 - excessive intensity of experiences, 35 - uncertainty, 18 - obsessive thoughts, 131 -burning 
sensation in one's throat/ heartburn, 37 - exaggeration in trying to avoid illness, 70 - social phobia, 
66 - difficulties in concentrating, 13 - muscle cramps, 73 - temporary speech-loss, 41 -anxiety in 
vehicles - trains, buses, etc., 27 - sexual dysfunction (no erection, premature ejaculation etc.), 
38 - obsessive thoughts of an aggressive character, 53 - ticks, 107 - pains of sexual organs
TABLE II
Symptoms: 37 - exaggeration in trying to avoid illness, 52 - compulsion to wash hands and 
touch objects etc., 38 - obsessive thoughts of aggressive content, 62 - suicidal tendencies, 
67 - lowering of sexual drive, 74 - constipation, 83 - faintness, 34 - blood strikes to the head, 
12 - compulsive actions (checking), 95 - daydreams, 55 - feeling of life helplessness, 72 - psycho­
motor action slowing down, 17 - conviction of having a somatic disease, 60 - hot or cold spells, 
43 - momentary paresis of hands or limbs, 3 - feeling of having a lump in your throat, 46 -feeling of 
lower brightness of thinking, 48 - derealisations (feeling of unreality of environment), 50 - avoid­
ance of people, 51 - fainting, 90 - feeling of being under other peoples' influences, 98 - excessive 
thirst, 106 - difficulty in thinking, 118 - feeling of protest/rebellion, 63 - temporary loss of eye-sight 
or hearing, 73 - temporary speech-loss, 80 - getting red on the face, neck, 93 - muscle cramps, 
1 - being afraid of heights, 33 - stuttering, 135 - buzzing in one’s ears.

